A detailed history of Aspire Private Capital, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Aspire Private Capital, LLC holds 12,995 shares of MRK stock, worth $1.29 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
12,995
Previous 12,033 7.99%
Holding current value
$1.29 Million
Previous $1.49 Million 0.94%
% of portfolio
0.35%
Previous 0.39%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$111.15 - $128.97 $106,926 - $124,069
962 Added 7.99%
12,995 $1.48 Million
Q2 2024

Jul 15, 2024

BUY
$123.8 - $132.96 $103,125 - $110,755
833 Added 7.44%
12,033 $1.49 Million
Q1 2024

Apr 18, 2024

BUY
$113.24 - $131.95 $149,590 - $174,305
1,321 Added 13.37%
11,200 $1.48 Million
Q4 2023

Feb 01, 2024

BUY
$100.18 - $109.02 $30,254 - $32,924
302 Added 3.15%
9,879 $1.08 Million
Q3 2023

Nov 03, 2023

BUY
$102.95 - $114.33 $39,018 - $43,331
379 Added 4.12%
9,577 $985,000
Q2 2023

Jul 24, 2023

SELL
$108.61 - $118.38 $87,974 - $95,887
-810 Reduced 8.09%
9,198 $1.06 Million
Q1 2023

May 30, 2023

SELL
$102.94 - $114.86 $4,529 - $5,053
-44 Reduced 0.44%
10,008 $1.06 Million
Q1 2023

May 03, 2023

SELL
$102.94 - $114.86 $4,529 - $5,053
-44 Reduced 0.44%
10,008 $1.06 Million
Q4 2022

May 30, 2023

BUY
$87.44 - $112.11 $3,847 - $4,932
44 Added 0.44%
10,052 $1.12 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $47,654 - $61,099
545 Added 5.73%
10,052 $1.12 Million
Q3 2022

Nov 10, 2022

SELL
$84.53 - $94.96 $12,087 - $13,579
-143 Reduced 1.48%
9,507 $819,000
Q2 2022

Aug 01, 2022

SELL
$83.49 - $94.64 $67,125 - $76,090
-804 Reduced 7.69%
9,650 $880,000
Q1 2022

May 10, 2022

BUY
$73.51 - $82.4 $162,898 - $182,598
2,216 Added 26.9%
10,454 $858,000
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $436,932 - $547,314
6,045 Added 275.65%
8,238 $631,000
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $5,232 - $5,754
73 Added 3.44%
2,193 $165,000
Q2 2021

Aug 09, 2021

SELL
$70.31 - $77.77 $108,980 - $120,543
-1,550 Reduced 42.23%
2,120 $165,000
Q1 2021

May 26, 2021

SELL
$68.86 - $81.11 $256,090 - $301,648
-3,719 Reduced 50.33%
3,670 $283,000
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $115,908 - $128,634
1,615 Added 27.97%
7,389 $604,000
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $66,959 - $75,899
915 Added 18.83%
5,774 $479,000
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $97,954 - $111,460
1,391 Added 40.11%
4,859 $379,000
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $103,023 - $142,795
1,626 Added 88.27%
3,468 $267,000
Q4 2019

Feb 11, 2020

BUY
$77.58 - $87.54 $2,172 - $2,451
28 Added 1.54%
1,842 $168,000
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $8,520 - $9,288
112 Added 6.58%
1,814 $153,000
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $11,872 - $13,870
170 Added 11.1%
1,702 $143,000
Q1 2019

May 13, 2019

BUY
$69.58 - $79.36 $56,359 - $64,281
810 Added 112.19%
1,532 $127,000
Q4 2018

Feb 25, 2019

BUY
$65.24 - $75.71 $42,406 - $49,211
650 Added 902.78%
722 $55,000
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $4,697 - $5,451
72 New
72 $55,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Aspire Private Capital, LLC Portfolio

Follow Aspire Private Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.